Stable Angina Pectoris: 3. Medical Treatment

Pharmacologic Aspects of Cigarette Smoking and Nicotine Addiction

1988 • 982 citations

Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem

1980 • 865 citations

IMPACT OF SEXUAL AND PHYSICAL ABUSE ON WOMEN'S MENTAL HEALTH

1988 • 603 citations

The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response.

1981 • 467 citations

Propranolol-Withdrawal Rebound Phenomenon

1975 • 400 citations

Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin.

1986 • 371 citations

PROLONGED PERITONEAL DIALYSIS FOR CHRONIC RENAL FAILURE

1964 • 328 citations

PERIPHERAL VASCULAR DISEASE

1940 • 303 citations

The clinical importance of cardioselectivity and lipophilicity in beta blockers

1980 • 264 citations

Coronary Artery Syndromes After Sudden Propranolol Withdrawal

1974 • 231 citations

Effect of Intervals between Doses on the Development of Tolerance to Isosorbide Dinitrate

1987 • 218 citations

Antianginal effects of nitroglycerin patches

1984 • 210 citations

Mechanism of propranolol withdrawal phenomena.

1979 • 207 citations

Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease

1981 • 198 citations

Effects of verapamil on myocardial performance in coronary disease.

1979 • 182 citations

Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease.

1983 • 178 citations

Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris

1981 • 169 citations

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders

1984 • 168 citations

The effect of diltiazem and propranolol, alone and in combination, on exercise performance and left ventricular function in patients with stable effort angina: a double-blind, randomized, and placebo-controlled study.

1983 • 159 citations

Blood levels after sublingual nitroglycerin.

1979 • 153 citations

Hemodynamic effects of nitroglycerin and long-acting nitrates

1985 • 151 citations

Nifedipine and propranolol: A beneficial drug interaction

1981 • 149 citations

Modulation of calcium channel function by drugs

1985 • 137 citations

Transdermal isosorbide dinitrate in angina pectoris: Effect of acute and sustained therapy

1984 • 129 citations

VERAPAMIL IN CHRONIC STABLE ANGINA

1980 • 124 citations

Unpredictable response to nifedipine in severe cardiac failure.

1980 • 123 citations

Molecular Pharmacology of the Calcium Channel

1984 • 122 citations

Production of ischaemic cardiac pain by nifedipine.

1978 • 122 citations

VERAPAMIL POTENTIATES CARBAMAZEPINE NEUROTOXICITY: A CLINICALLY IMPORTANT INHIBITORY INTERACTION

1986 • 121 citations

NEGLIGIBLE SUBLINGUAL ABSORPTION OF NIFEDIPINE

1987 • 120 citations

Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: Report of a cooperative clinical trial

1982 • 113 citations

Nifedipine and beta-blockade as a cause of cardiac failure.

1982 • 112 citations

Cardiology: Fundamentals and Practice.

1987 • 112 citations

Effects of cimetidine and ranitidine on hepatic drug metabolism

1982 • 111 citations

Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy.

1980 • 111 citations

Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.

1988 • 106 citations

Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure

1985 • 96 citations

Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure

1984 • 95 citations

Prevention of tolerance to nitroglycerin patches by overnight removal

1987 • 94 citations

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications

1979 • 94 citations

HYDRALLAZINE (APRESOLINE®) HYDROCHLORIDE

1953 • 94 citations

Intravenous Beta-Blockade in Coronary Heart Disease

1982 • 92 citations

Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: A placebo-controlled, double-blind, randomized, crossover study

1985 • 87 citations

Direct and reflex cardiostimulating effects of hydralazine

1977 • 87 citations

Dose response effectiveness of propranolol for the treatment of angina pectoris.

1975 • 86 citations

Acute elevation of blood carboxyhemoglobin to 6% impairs exercise performance and aggravates symptoms in patients with ischemic heart disease

1988 • 86 citations

Effects of a calcium-entry blocker (diltiazem) on regional myocardial flow and function during exercise in conscious dogs.

1984 • 85 citations

Nifedipine-lnduced Hypotension and Myocardial Ischemia in Refractory Angina Pectoris

1985 • 77 citations

Nifedipine-induced renal dysfunction

1984 • 76 citations

Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.

1987 • 76 citations

Effect of verapamil on normal sinoatrial node function and on sick sinus syndrome

1978 • 75 citations

Diltiazem-induced blockade of sympathetically mediated constriction of normal and diseased coronary arteries: lack of epicardial coronary dilatory effect in humans.

1984 • 74 citations

beta‐Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.

1976 • 73 citations

Evaluation of “coronary vasodilators” by coronary arteriography

1964 • 73 citations

Adrenergic beta receptor blockade: Hemodynamic importance of intrinsic sympathomimetic activity at rest

1981 • 71 citations

Treatment of angina pectoris with nifedipine: importance of dose titration.

1983 • 62 citations

Clinical outcome after treatment of rest angina with calcium blockers: Comparative experience during the initial year of therapy with diltiazem, nifedipine, and verapamil

1983 • 61 citations

Effect of nitroglycerin and nifedipine on subendocardial perfusion in the presence of a flow-limiting coronary stenosis in the awake dog.

1982 • 59 citations

Increased exercise tolerance after nitroglycerin oral spray: a new and effective therapeutic modality in angina pectoris.

1983 • 58 citations

Verapamil and digoxin: Their respective effects on atrial fibrillation and their interaction

1982 • 55 citations

Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris

1985 • 51 citations

Effect of food on nifedipine pharmacokinetics

1987 • 51 citations

Pharmacokinetics of diltiazem in severe renal failure

1983 • 50 citations

Effects of calcium-channel blocking agents on left ventricular diastolic function in hypertrophic cardiomyopathy and in coronary artery disease

1985 • 45 citations

Gynecomastia Associated With Calcium Channel Blocker Therapy

1988 • 43 citations

Drug interactions with the calcium-entry blockers.

1987 • 40 citations

Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability.

1975 • 37 citations

Provocation of myocardial ischemic events during initiation of vasodilator therapy for severe chronic heart failure

1981 • 36 citations

Influence of severity of ventricular dysfunction on hemodynamic response to intravenously administered verapamil in ischemic heart disease

1982 • 30 citations

Propranolol in angina pectoris: Comparison of therapy given two and four times daily

1980 • 28 citations

The Effects of Slow Channel Blockers and Beta Blockers on Atrioventricular Nodal Conduction

1988 • 28 citations

Effect of food ingestion on nifedipine absorption and haemodynamic response

1985 • 27 citations

Calcium blockers in coronary heart disease. Part II.

1981 • 26 citations

Aortic input impedance in cardiovascular disease

1982 • 25 citations

Observations on Angina Pectoris during Drug Treatment of Hypertension

1956 • 25 citations

Calcium Entry Blockers

1988 • 22 citations

Potentiation by nifedipine and diltiazem of the hypotensive response after contrast angiography

1985 • 21 citations

Evaluation of the Efficacy of Slow-Release Nifedipine in Systemic Hypertension by Ambulatory Intraarterial Blood Pressure Monitoring

1985 • 21 citations

Evaluation of the Pharmacodynamic and Pharmacokinetic Interaction Between Calcium Antagonists and Digoxin

1986 • 21 citations

Efficacy of sustained-release verapamil in chronic stable angina pectoris

1987 • 19 citations

A comparison of nine calcium ion antagonists and propranolol: Exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris

1987 • 18 citations

Comparison of selective (beta1) and nonselective (beta1 and beta2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris

1987 • 18 citations

Beta-adrenoceptor blocking agents : the pharmacological basis of clinical use

1976 • 17 citations

Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris

1981 • 17 citations

Circulatory Effects and Clinical Uses of Beta-Adrenergic Blocking Drugs.

1972 • 16 citations

Comparison of antianginal actions of verapamil and propranolol.

1981 • 15 citations

Cardiovascular Hemodynamics of Bicycle and Handgrip Exercise in Normal Subjects Before and After Administration of Propranolol

1984 • 14 citations

Medical treatment of angina pectoris VIII. Miscellaneous antianginal drugs

1973 • 13 citations

Rationale for calcium entry-blocking drugs in systemic hypertension complicated by coronary artery disease

1985 • 11 citations

Effects of calcium entry blockade on left ventricular dynamics in exercising dogs

1986 • 11 citations

Nitroglycerin oral spray: Evaluation of its coronary artery dilative action by quantitative angiography

1988 • 11 citations

Effect of New -Adrenergic Blocking Agent

1975 • 6 citations

Effect of propranolol and verapamil on oxygen utilization, acidosis and fatigue during exercise in stable angina pectoris

1987 • 5 citations

[Medical treatment of angina pectoris].

1984 • 3 citations

Risk of provoking myocardial ischemic events during initiation of vasodilator therapy for chronic heart failure: Evaluation of 40 consecutive patients with ischemic cardiomyopathies

1980 • 3 citations

Labetalol in the treatment of angina pectoris.

1987 • 2 citations

Relation of transdermal nitroglycerin efficacy with dosage in different subsets of patients

1988 • 2 citations

Use of combined calcium channel blockers for therapy of refractory angina pectoris.

1986 • 1 citations